Jasper Therapeutics (JSPR) Earnings Date & Reports

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

JSPR is expected to report earnings to rise 1.80% to -10 cents per share on November 05

Jasper Therapeutics JSPR Stock Earnings Reports

Q3'26

Est.

$-0.10

Q2'26

Beat

by $0.18

Q1'26

Beat

by $0.63

Q4'25

Beat

by $1.78

Q3'25

Beat

by $0.87

The last earnings report on August 17 showed earnings per share of -10 cents, beating the estimate of -28 cents. With 59.16K shares outstanding, the current market capitalization sits at 20.83M.

View a ticker or compare two or three

JSPR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for JSPR